Immunotherapy

Cancer immunotherapy (sometimes called immuno-oncology) is the stimulation of the immune system to treat cancer, improving on the immune system's natural ability to fight the disease.

Read more in the app

Immunotherapy found effective against a subtype of difficult-to-treat ovarian cancer

Maternal genes enable trophoblastic tumor relapse after immunotherapy

Preoperative chemo-immunotherapy more effective than immunotherapy alone in patients with head and neck cancer - EurekAlert!

Finding a tumor’s soft spot to power-up immunotherapy - EurekAlert!

Scientists uncover drivers of recurrent arthritis after immunotherapy, suggesting potential biomarkers - EurekAlert!

How tumors outsmart immunotherapy: DDB1-driven ubiquitination sends PD-L1 into the nucleus to fuel anti-PD-1 resistance. - EurekAlert!

CRISPR makes prostate cancer vulnerable to immunotherapy

New strategy could prevent T cell exhaustion and boost immunotherapy - EurekAlert!

The gut as a key player in immunotherapy for MS - EurekAlert!

New Tool Supercharges Immunotherapy Against Prostate Cancer

Emerging roles of hepatocellular carcinoma gene signatures in prognosis and immunotherapy: challenges and opportunities - EurekAlert!

This Popular Workout Supplement May Give Cancer Immunotherapy a Big Boost

FDA-approved drug may finally help immunotherapy defeat rare liver cancer

New alliance study tests immunotherapy to prevent lung cancer recurrence - EurekAlert!

Can immunotherapy help more liver cancer patients reach transplantation? - EurekAlert!

Adding immunotherapy to radiation improves disease-free survival in localized prostate cancer - EurekAlert!

Addition of immunotherapy continues to show survival benefit in prolonged follow-up in NRG Oncology trial for primary advanced stage or recurrent endometrial cancer - EurekAlert!

Immunotherapy shows early promise in sparing cancer patients from bladder removal - EurekAlert!

Early myocarditis onset after immunotherapy may predict treatment-related fatality - EurekAlert!

A deep learning pathomics platform may help predict response to immunotherapy in lung cancer patients - EurekAlert!